| GTO ID | GTC4011 |
| Trial ID | NCT02028442 |
| Disease | Colorectal Cancer | Bladder Cancer |
| Altered gene | E1A|E1B |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | DNA oncolytic virus |
| Treatment | ColoAd1|Enadenotucirev |
| Phase | Phase1|Phase2 |
| Recruitment status | Completed |
| Title | A Clinical Study Of Enadenotucirev Administered by Sub-Acute Fractionated Intravenous Injection: Dose Escalation in Metastatic Epithelial Solid Tumours and Randomised Controlled Trial in Metastatic Colorectal Cancer |
| Year | 2012 |
| Country | Belgium|Spain |
| Company sponsor | Akamis Bio |
| Other ID(s) | ColoAd1-1001 |
| Vector information | |||||||||
|
|||||||||
| Cohort 1 | |||||||||
|
|||||||||